Related Experiment Video
Updated: Jun 13, 2026
08:28
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Suicide risk during anticonvulsant treatment
Maurizio Pompili1, Roberto Tatarelli, Paolo Girardi
1Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. maurizio.pompili@uniroma1.it
Pharmacoepidemiology and Drug Safety
|May 4, 2010
Summary
Anticonvulsant medications may increase suicidal behavior risk, particularly in epilepsy patients. Ongoing mood assessments are crucial for all patients on these drugs.
Area of Science:
- Neuroscience
- Clinical Pharmacology
- Psychiatry
Background:
- Anticonvulsant drugs are widely prescribed for epilepsy and psychiatric conditions.
- Emerging research indicates a potential association between anticonvulsant use and increased suicidal behaviors.
Purpose of the Study:
- To review and synthesize current research on the risk of suicidal behaviors in patients treated with anticonvulsants.
- To differentiate the risk in epilepsy versus psychiatric patient populations.
Main Methods:
- Review of existing research findings and associational studies.
- Analysis of limitations in current evidence, including uncontrolled variables.
Main Results:
- Evidence suggests a clearer association between anticonvulsants and suicidal behaviors in epilepsy patients compared to those with psychiatric disorders.
- Current studies are limited by associational data, potentially confounded by uncontrolled factors.
Conclusions:
- While a potential risk exists, current evidence is largely associational and requires cautious interpretation.
- Clinical practice should include routine monitoring of mood and suicidal ideation in all patients receiving anticonvulsants, regardless of diagnosis.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...